Pfizer in talks to buy cancer drugmaker Seagen - WSJ

United States News News

Pfizer in talks to buy cancer drugmaker Seagen - WSJ
United States Latest News,United States Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 97%

Pfizer Inc is in early-stage talks to acquire cancer drugmaker Seagen Inc in what could be a multi-billion dollar deal, the Wall Street Journal reported on Sunday, citing people familiar with the matter.

Seagen had a market capitalization of roughly $30 billion, as of Friday's close., in a deal that would have been worth $40 billion or more, the Journal reported last year, but the two sides failed to reach an agreement, according to multiple reports.

Seagen's shares have fallen nearly 10% since July, when the deal talks with Merck were first reported. They rose 12.3% to $182 in premarket trading on Monday. Pfizer declined to comment on the WSJ report, while Seagen did not immediately respond to a Reuters request for comment.it expects to lose $17 billion in annual sales between 2025 and 2030 due to patent expirations for top drugs, and sales of its COVID-19 products have begun to decline after they contributed to an unprecedented surge in revenue.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer in talks to buy Seagen for likely for more than $30 bln - WSJPfizer in talks to buy Seagen for likely for more than $30 bln - WSJPfizer Inc is in early talks to acquire drugmaker Seagen Inc , the Wall Street Journal reported late on Sunday, citing people familiar with the matter.
Read more »

Pfizer eyes takeover of biotech Seagen, at value of more than $30 billionPfizer eyes takeover of biotech Seagen, at value of more than $30 billionPfizer Inc. is in talks to acquire biotech Seagen Inc., according to people familiar with the matter, the latest potential deal for a big drug company aimed...
Read more »

WSJ News Exclusive | Pfizer in Talks to Acquire Seagen in Deal Likely Valued at More Than $30 BillionBreaking: Pfizer is in early-stage talks to acquire biotech Seagen, valued at about $30 billion, and its pioneering targeted cancer therapies
Read more »

Merck's Big Upgrade: 4 Big Analyst Calls | Pro Recap | Investing.comMerck's Big Upgrade: 4 Big Analyst Calls | Pro Recap | Investing.comStocks Analysis by Garrett Cook covering: Alcoa Corp, Merck & Company Inc, Wingstop Inc, Dun And Bradstreet Holding Inc. Read Garrett Cook's latest article on Investing.com
Read more »

Streaming Confusion: WSJ Readers Struggle to Make Sense of It AllStreaming Confusion: WSJ Readers Struggle to Make Sense of It AllWe asked Wall Street Journal readers how they're juggling streaming services, or whether they’ve found a simpler way to just watch TV
Read more »

WSJ News Exclusive | Lab Leak Most Likely Origin of Covid-19 Pandemic, Energy Department Now SaysWSJ News Exclusive | Lab Leak Most Likely Origin of Covid-19 Pandemic, Energy Department Now SaysThe Energy Department joins the FBI in saying the virus likely spread via a mishap at a Chinese laboratory. Four other agencies, along with a national intelligence panel, still judge that it was likely the result of a natural transmission, and two are undecided.
Read more »



Render Time: 2025-02-22 16:09:16